Abstract
Active immunization with the amyloid β (Aβ) peptide has been shown to decrease brain Aβ deposition in transgenic mouse models of Alzheimer's disease and certain peripherally administered anti-Aβ antibodies were shown to mimic this effect. In exploring factors that alter Aβ metabolism and clearance, we found that a monoclonal antibody (m266) directed against the central domain of Aβ was able to bind and completely sequester plasma Aβ. Peripheral administration of m266 to PDAPP transgenic mice, in which Aβ is generated specifically within the central nervous system (CNS), results in a rapid 1,000-fold increase in plasma Aβ, due, in part, to a change in Aβ equilibrium between the CNS and plasma. Although peripheral administration of m266 to PDAPP mice markedly reduces Aβ deposition, m266 did not bind to Aβ deposits in the brain. Thus, m266 appears to reduce brain Aβ burden by altering CNS and plasma Aβ clearance.
Bibliography
DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001). Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimerâs disease. Proceedings of the National Academy of Sciences, 98(15), 8850â8855.
References
35
Referenced
1,043
10.1126/science.275.5300.630
10.1016/S0925-4439(00)00043-0
10.1038/349704a0
10.1101/SQB.1996.061.01.056
10.1016/S0959-4388(97)80089-X
10.1172/JCI8728
10.1038/72237
10.1046/j.1471-4159.1996.67020880.x
10.1172/JCI10498
10.1006/nbdi.1997.0147
10.1146/annurev.ne.19.030196.000413
10.1046/j.1471-4159.1997.69010299.x
10.1038/ng1197-263
10.1073/pnas.95.26.15598
10.1172/JCI6179
10.1073/pnas.96.26.15233
10.1073/pnas.050004797
10.1006/bbrc.1994.2825
10.1073/pnas.93.9.4229
10.1073/pnas.94.4.1550
10.1038/359325a0
10.1074/jbc.273.7.4206
10.1523/JNEUROSCI.18-09-03261.1998
10.1042/bj3480359
10.1038/78682
10.1038/373523a0
10.1006/bbrc.1993.2582
10.1002/ana.410380413
10.1006/exnr.1999.7085
10.1073/pnas.89.16.7437
10.1074/jbc.274.29.20650
10.1021/bi001048s
10.1006/nbdi.2000.0364
10.1038/85525
10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 10:34 a.m.) |
Deposited | 3 years, 4 months ago (April 12, 2022, 11:56 p.m.) |
Indexed | 1 week, 6 days ago (Aug. 19, 2025, 6:01 a.m.) |
Issued | 24 years, 1 month ago (July 3, 2001) |
Published | 24 years, 1 month ago (July 3, 2001) |
Published Online | 24 years, 1 month ago (July 3, 2001) |
Published Print | 24 years, 1 month ago (July 17, 2001) |
@article{DeMattos_2001, title={Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer’s disease}, volume={98}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.151261398}, DOI={10.1073/pnas.151261398}, number={15}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={DeMattos, Ronald B. and Bales, Kelly R. and Cummins, David J. and Dodart, Jean-Cosme and Paul, Steven M. and Holtzman, David M.}, year={2001}, month=jul, pages={8850–8855} }